View in EDS

Chimeric antigen receptor-natural killer cell therapy in first-relapse epithelial ovarian cancer: an early health-economic evaluation in the Netherlands.

Saved in:
Bibliographic Details
Title: Chimeric antigen receptor-natural killer cell therapy in first-relapse epithelial ovarian cancer: an early health-economic evaluation in the Netherlands.
Authors: Seyahian A; Science Department IQ Health, Radboud University Medical Center, Nijmegen, The Netherlands. Electronic address: Abril.Seyahian@radboudumc.nl., Scholte M; Science Department IQ Health, Radboud University Medical Center, Nijmegen, The Netherlands; Department of Medical Imaging, Radboud University Medical Center, Nijmegen, The Netherlands., Gravesteijn C; Department of Laboratory Medicine - Laboratory of Hematology, Radboud University Medical Center, Nijmegen, Netherlands., Zusterzeel PLM; Department of Obstetrics and Gynecology, Radboud University Medical Center, Nijmegen, The Netherlands., De Jonge PKJD; Department of Laboratory Medicine - Laboratory of Hematology, Radboud University Medical Center, Nijmegen, Netherlands., de Goede A; Department of Pharmacy, Pharmacology and Toxicology, Radboud University Medical Center, Nijmegen, The Netherlands., Jansen JH; Department of Laboratory Medicine - Laboratory of Hematology, Radboud University Medical Center, Nijmegen, Netherlands., Bekkers RLM; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands; Department of Obstetrics and Gynecology, Catharina Hospital Eindhoven, The Netherlands; GROW School for Oncology and Reproduction, Maastricht University, Maastricht, The Netherlands., Ottevanger PB; Department of Obstetrics and Gynecology, Radboud University Medical Center, Nijmegen, The Netherlands., Dolstra H; Department of Laboratory Medicine - Laboratory of Hematology, Radboud University Medical Center, Nijmegen, Netherlands., Grutters JPC; Science Department IQ Health, Radboud University Medical Center, Nijmegen, The Netherlands.
Source: Cytotherapy [Cytotherapy] 2026 Jul; Vol. 28 (7), pp. 102822. Date of Electronic Publication: 2026 Apr 03.
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Country of Publication: England NLM ID: 100895309 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1477-2566 (Electronic) Linking ISSN: 14653249 NLM ISO Abbreviation: Cytotherapy Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 42134093
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Chimeric antigen receptor-natural killer cell therapy in first-relapse epithelial ovarian cancer: an early health-economic evaluation in the Netherlands.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Seyahian+A%22">Seyahian A</searchLink>; Science Department IQ Health, Radboud University Medical Center, Nijmegen, The Netherlands. Electronic address: Abril.Seyahian@radboudumc.nl.<br /><searchLink fieldCode="AU" term="%22Scholte+M%22">Scholte M</searchLink>; Science Department IQ Health, Radboud University Medical Center, Nijmegen, The Netherlands; Department of Medical Imaging, Radboud University Medical Center, Nijmegen, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Gravesteijn+C%22">Gravesteijn C</searchLink>; Department of Laboratory Medicine - Laboratory of Hematology, Radboud University Medical Center, Nijmegen, Netherlands.<br /><searchLink fieldCode="AU" term="%22Zusterzeel+PLM%22">Zusterzeel PLM</searchLink>; Department of Obstetrics and Gynecology, Radboud University Medical Center, Nijmegen, The Netherlands.<br /><searchLink fieldCode="AU" term="%22De+Jonge+PKJD%22">De Jonge PKJD</searchLink>; Department of Laboratory Medicine - Laboratory of Hematology, Radboud University Medical Center, Nijmegen, Netherlands.<br /><searchLink fieldCode="AU" term="%22de+Goede+A%22">de Goede A</searchLink>; Department of Pharmacy, Pharmacology and Toxicology, Radboud University Medical Center, Nijmegen, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Jansen+JH%22">Jansen JH</searchLink>; Department of Laboratory Medicine - Laboratory of Hematology, Radboud University Medical Center, Nijmegen, Netherlands.<br /><searchLink fieldCode="AU" term="%22Bekkers+RLM%22">Bekkers RLM</searchLink>; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands; Department of Obstetrics and Gynecology, Catharina Hospital Eindhoven, The Netherlands; GROW School for Oncology and Reproduction, Maastricht University, Maastricht, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Ottevanger+PB%22">Ottevanger PB</searchLink>; Department of Obstetrics and Gynecology, Radboud University Medical Center, Nijmegen, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Dolstra+H%22">Dolstra H</searchLink>; Department of Laboratory Medicine - Laboratory of Hematology, Radboud University Medical Center, Nijmegen, Netherlands.<br /><searchLink fieldCode="AU" term="%22Grutters+JPC%22">Grutters JPC</searchLink>; Science Department IQ Health, Radboud University Medical Center, Nijmegen, The Netherlands.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22100895309%22">Cytotherapy</searchLink> [Cytotherapy] 2026 Jul; Vol. 28 (7), pp. 102822. <i>Date of Electronic Publication: </i>2026 Apr 03.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>100895309 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1477-2566 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2214653249%22">14653249 </searchLink><i>NLM ISO Abbreviation: </i>Cytotherapy <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42134093
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.jcyt.2026.102822
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 102822
    Titles:
      – TitleFull: Chimeric antigen receptor-natural killer cell therapy in first-relapse epithelial ovarian cancer: an early health-economic evaluation in the Netherlands.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Seyahian A
      – PersonEntity:
          Name:
            NameFull: Scholte M
      – PersonEntity:
          Name:
            NameFull: Gravesteijn C
      – PersonEntity:
          Name:
            NameFull: Zusterzeel PLM
      – PersonEntity:
          Name:
            NameFull: De Jonge PKJD
      – PersonEntity:
          Name:
            NameFull: de Goede A
      – PersonEntity:
          Name:
            NameFull: Jansen JH
      – PersonEntity:
          Name:
            NameFull: Bekkers RLM
      – PersonEntity:
          Name:
            NameFull: Ottevanger PB
      – PersonEntity:
          Name:
            NameFull: Dolstra H
      – PersonEntity:
          Name:
            NameFull: Grutters JPC
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 07
              Text: 2026 Jul
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1477-2566
          Numbering:
            – Type: volume
              Value: 28
            – Type: issue
              Value: 7
          Titles:
            – TitleFull: Cytotherapy
              Type: main
ResultId 1